2024: Volume 7, Issue 6
Perspective P.1-2
T-Cell Therapies: Revolutionizing the Landscape of Tumor Immunology
Author(s):
Sambriny Pirnie
DOI: 10.35841/aajcit-7.6.236
Perspective P.1-1
The Role of Innate Immunity in Tumor Surveillance and Elimination
Author(s):
Anney Robertson
DOI: 10.35841/aajcit-7.6.237
Commentary P.1-2
Clinical Advances in Cancer Immunotherapy: Bridging Research and Practice
Author(s):
Joseph Kennedy
DOI: 10.35841/aajcit-7.6.238
Commentary P.1-2
Personalized Cancer Immunotherapy: Tailoring Treatment to Individual Immune Profiles
Author(s):
Ann Lander
DOI: 10.35841/aajcit-7.6.239
Opinion Article P.1-2
The Role of Tumor-Infiltrating Lymphocytes in Predicting Immunotherapy Outcomes
Author(s):
Karl Tolley
DOI: 10.35841/aajcit-7.6.240
Opinion Article P.1-2
Emerging Biomarkers in Tumor Immunology for Personalized Cancer Treatment
Author(s):
Alane Gouldy
DOI: 10.35841/aajcit-7.6.241
Rapid Communication P.1-2
Immune-Related Adverse Events in Cancer Therapy: Management and Best Practices
Author(s):
Henri Gord
DOI: 10.35841/aajcit-7.6.242
Short Communication P.1-2
Immune Checkpoint Inhibitors: A New Frontier in Tumor Immunology
Author(s):
Margaret Henderson
DOI: 10.35841/aajcit-7.6.244
Rapid Communication P.1-2
Overcoming Immune Evasion Mechanisms in Cancer Therapy
Author(s):
Stein Rivert
DOI: 10.35841/aajcit-7.6.245
Review Article P.1-7
Incidence and management of Cytokine release syndrome in CAR-T cell therapy for solid tumors: A systematic review of phase I trials.
Author(s):
Jasraj Singh Anand1 *, Indermeet Anand2, Dr. Maheshvari Patel3